Metformin's Unexpected Mechanism: A Breakthrough in Diabetes Treatment

Metformin has been a cornerstone treatment for type 2 diabetes for over 60 years, primarily known for its ability to lower blood sugar by reducing glucose production in the liver and enhancing insulin sensitivity. However, a recent study from Baylor College of Medicine has revealed that metformin also acts directly in the brain, specifically through a pathway involving the protein Rap1 in the ventromedial hypothalamus (VMH). This discovery, published in *Science Advances*, could lead to more targeted diabetes therapies.

Science DailyMetformin treated diabetes for 60 years. Now scientists find it works in the brain tooScienceAlertMetformin’s hidden brain pathway revealed after 60 years as 2025 study shifts thinking

The research team, led by Dr. Makoto Fukuda, found that metformin travels to the VMH, where it suppresses Rap1 activity. In experiments with genetically engineered mice lacking Rap1 in the VMH, metformin failed to lower blood sugar levels, indicating that Rap1 is essential for the drug's effectiveness in the brain. Notably, the brain responds to much lower concentrations of metformin compared to the liver and gut, suggesting a unique mechanism of action that could be exploited for new treatments.

Metformin’s hidden brain pathway revealed after 60 years as 2025 study shifts thinkingScience DailyMetformin treated diabetes for 60 years. Now scientists find it works in the brain tooScienceAlert

Beyond its role in diabetes management, metformin has been associated with various health benefits, including potential effects on brain aging. The study opens avenues for investigating whether the Rap1 signaling pathway contributes to these additional effects. Previous research has indicated that metformin may slow biological aging and reduce the risk of long COVID, further emphasizing its potential as a gerotherapeutic agent.

ScienceAlertMetformin treated diabetes for 60 years. Now scientists find it works in the brain tooScience DailyMetformin’s hidden brain pathway revealed after 60 years as 2025 study shifts thinking

Dr. Fukuda stated, "This discovery changes how we think about metformin. It's not just working in the liver or the gut, it's also acting in the brain." He emphasized the need for human studies to confirm these findings and explore the implications for developing new diabetes treatments that target brain pathways.

Science Daily

While the findings are promising, experts caution that the current evidence is based on animal models, and confirmation in human studies is necessary before clinical applications can be realized. Concerns remain about the variability of human physiology and whether the Rap1 pathway will have the same significance in people as observed in mice.

Metformin’s hidden brain pathway revealed after 60 years as 2025 study shifts thinking

The next steps involve conducting human studies to validate the role of the Rap1 pathway in glucose metabolism and to explore the potential for developing brain-targeted therapies. Researchers are particularly interested in whether low-dose brain exposure to metformin can produce metabolic effects similar to those seen in animal models.

Metformin’s hidden brain pathway revealed after 60 years as 2025 study shifts thinkingScienceAlertScience DailyMetformin treated diabetes for 60 years. Now scientists find it works in the brain too

• “It's been widely accepted that metformin lowers blood glucose primarily by reducing glucose output in the liver.” — Dr. Makoto Fukuda, Baylor College of Medicine

ScienceAlert

• “These findings open the door to developing new diabetes treatments that directly target this pathway in the brain,” — Dr. Makoto Fukuda

ScienceAlert

• “This discovery changes how we think about metformin.” — Dr. Makoto Fukuda

Metformin treated diabetes for 60 years. Now scientists find it works in the brain too

• “We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.” — Dr. Makoto Fukuda

ScienceAlert

The study's findings represent a significant shift in understanding metformin's mechanisms, potentially leading to enhanced diabetes treatments and broader health applications.

ScienceAlert